SCIESCOPUSQ1
CANCER IMMUNOLOGY IMMUNOTHERAPY
SPRINGER, Germany
CANCER IMMUNOLOGY IMMUNOTHERAPY은(는) SPRINGER(Germany)에서 발행하는 학술지입니다. 식별자: ISSN 0340-7004, eISSN 1432-0851. SCIE, SCOPUS에 등재되어 있습니다. 지표: JIF 5.1, CiteScore 10.7, SJR 1.716, SNIP 0.99. 주제 분야: IMMUNOLOGY, ONCOLOGY. tlooto에서 이 학술지의 논문 6,518편을 볼 수 있습니다.
CiteScore
10.70
Scopus 인용 지표
SJR
1.716
SCImago 저널 순위
SNIP
0.99
분야 보정 인용 영향력
Percentage rank
-
JIF 백분위 순위
저널 기본 정보
- ISSN
- 0340-7004
- eISSN
- 1432-0851
- 약어
- CANCER IMMUNOL IMMUN
- 출판사
- SPRINGER
- 국가
- Germany
Web of Science 카테고리
SCIEIMMUNOLOGY, ONCOLOGY
Scopus ASJC 카테고리
1306 Cancer Research2403 Immunology2723 Immunology and Allergy2730 Oncology
키워드
Oncology | Immunology
이 학술지의 논문
최근 논문
- Rosuvastatin enhances the efficacy of venetoclax-azacitidine in older acute myeloid leukemia patients via reducing T-cell exhaustion
2026
- CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect
2026
- Comparative efficacy of combination regimens based on interventional therapy and immune checkpoint inhibitors (ICIs) in patients with intermediate- and advanced-stage hepatocellular carcinoma: a systematic review, meta-analysis, and network meta-analysis
2026 · 인용 1회
- AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study
2026
- NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
2026
많이 인용된 논문
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
2008 · 인용 1,279회
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
2007 · 인용 1,273회
- A listing of human tumor antigens recognized by T cells
2001 · 인용 810회
- An immune-active tumor microenvironment favors clinical response to ipilimumab
2012 · 인용 724회
- Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
2005 · 인용 676회